pharmaphorum

MARCH 17, 2022

The uptake of digital health tools during the pandemic has been enormous due to improved access they provide to healthcare. In this article, Ben Hargreaves asks whether there are gaps in those utilising these solutions and what action is being taken to address this. Digital health has a tremendous capacity to transform the healthcare industry, with the ability to provide easy access to a multitude of services and new types of therapies.

145

145

Outsourcing Pharma

MARCH 14, 2022

The pharma company and academic institution will explore the viability of a psychedelic treatment to help patients suffering from cancer-related distress.

122

122

Pharma Tutor

MARCH 16, 2022

ARTICLE ON FUTURISTIC APPROACH FOR MEDICAL DIAGNOSTICS ; BIOCHIP. About Author. Meenu Maurya. Email : meenudinesh15@gmail.com. admin. Wed, 03/16/2022 - 15:06. Tags. Articles.

65

65

Roots Analysis

MARCH 16, 2022

Over the years, applications of exosomes in therapeutics have undergone an evolutionary change, in terms of cost of research, technology used, and duration of the study. Moreover, various startups and small firms have entered into collaborations in order to advance their innovations and offer specialized research expertise, services and technologies.

Hospitals 59

Hospitals 59

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

MARCH 13, 2022

The FDA has cleared AstraZeneca and Merck & Co’s Lynparza as an adjuvant or neoadjuvant treatment for breast cancer, extending its lead over pretenders to its PARP inhibitor crown. The new approval is for use in patients with BRCA-mutated, HER2-negative early-stage breast cancer who have already been treated with chemotherapy – either before or after surgery – and are at high risk of the disease coming back.

FDA 140

FDA Chemotherapy Labelling 140

Outsourcing Pharma

MARCH 14, 2022

An executive from the AI specialist discusses how recent advances have provided opportunities for industry professionals to champion new ways of thinking.

106

106

Pharma Mirror

MARCH 18, 2022

HONG KONG, Sisram Medical Ltd (the “Company” or “Sisram”, stock code: 1696.HK; together with its subsidiaries referred as the “Group”), a global consumer wellness group, featuring a never-before-seen synergistic ecosystem of business building blocks and consumer-focused branding, ranging from medical aesthetics capital equipment, via injectables therapy, aesthetic dentistry, personal care and more, today announced its audited consolidated annual results for th

52

52

pharmaphorum

MARCH 15, 2022

Japanese pharma Eisai has backed away from its 50:50 profit-sharing arrangement with Biogen for troubled Alzheimer’s therapy Aduhelm, handing over full responsibility to its US counterpart. The changes to the terms of their longstanding collaboration on Aduhelm (aducanumab) means that Eisai’s profit-share converts to a simple royalty rate on revenues from 1 January next year.

Insurance 118

Insurance 118

Outsourcing Pharma

MARCH 16, 2022

An expert from the R&D tech provider discusses how automation, integration, and other tools can help with effective access and analysis of lab information.

100

100

Tria Health Blog

MARCH 16, 2022

The theme for National Nutrition Month is “Celebrate a World of Flavors”. With that in mind, we wanted to provide healthy recipes from other cultures that you can make in celebration of this month.

52

52

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Board Vitals - Pharmacist

MARCH 16, 2022

There’s no way around it, medical school is expensive and unfortunately for medical students, the costs have been increasing over the past several years. According to the Association of American Medical Colleges , the average cost of medical school including tuition, fees, and health insurance for first-year students attending in-state public schools in 2021-2022 was $39,237, a 29% increase from the cost in 2012-13 ($30,192).

Medical Schools 52

Medical Schools Documentation Insurance 52

pharmaphorum

MARCH 14, 2022

AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing application. The US regulator has asked for additional clinical data, according to AZ, which said it remains committed to brining the drug to patients with the inflammatory condition, which results in the growth of nasal polyps in the nose that can sometimes require surgical intervention.

FDA 116

FDA 116

Outsourcing Pharma

MARCH 16, 2022

While strides have been made recruiting more representative patient populations, more can and should be done, according to an Oracle Health Sciences leader.

100

100

NF2 BioSolutions

MARCH 16, 2022

Hi I’m Amy. My NF journey begun at 10, well that’s when we found the first tumour. Doctors can’t be sure if I lived with it my whole life, since, unlike many people with NF, the genetic defect does not run in my family. Lucky me eh!? I am very fortunate that here in the U.K., I am treated by an entire team of NF specialists from Consultants to Nurses to Psychologists I have access to a tonne of support.

Documentation 52

Documentation 52

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Birth Control Pharmacist

MARCH 14, 2022

Can pharmacy students advocate for pharmacists prescribing hormonal contraceptives? YES, that is exactly what Wilson Pace , a graduate of the University of Utah College of Pharmacy did. When Wilson heard about the barriers and costs that women experience when accessing contraceptives. His perseverance and dedication to advocacy as a pharmacy student allowed him to take action in his leadership class.

52

52

pharmaphorum

MARCH 17, 2022

Researchers in Germany are have found a possible link between mild COVID-19 infection and an increased risk of type 2 diabetes, although they caution the signal needs further investigation. The team from Heinrich Heine University in Dusseldorf and healthcare data science company IQVIA identified the possible correlation after analysing health records from 8.8 million patients registered at 1,171 health practices across Germany, including almost 36,000 who had been diagnosed with mild COVID-19.

Hospitals 114

Hospitals 114

Outsourcing Pharma

MARCH 16, 2022

A leader from the patient recruitment specialist discusses the industryâs ongoing challenges with patient population diversity, and potential solutions.

88

88

Pharma Marketing Network

MARCH 14, 2022

Tune in and watch the Pharma Marketing Network and industry experts from Novo Nordisk, Eisai, GSK, Otsuka, and more during part 1 of a 2 part series on engagement. This PMN HCP Engagement Summit focused HCP Engagement throughout the following panels: Modular Content: Making It Work. Get insights for pharma marketing insiders on restructuring your content strategy allowing more flexibility and agility to deliver more relative content to your customers.

52

52

Roots Analysis

MARCH 13, 2022

Over the years, the rising popularity of biologics has led to a paradigm shift in the healthcare industry. In the last decade alone, the annual number of approvals of biopharmaceuticals (including monoclonal antibodies, recombinant proteins, vaccines and gene therapies), by the US FDA, have steadily risen. In fact, over 8,000 biological pharmaceutical products are currently under clinical investigation worldwide.

Vaccines 52

Vaccines Compounding FDA 52

pharmaphorum

MARCH 15, 2022

A group of pharma companies and academic groups have joined forces with the Digital Medicine Society (DiMe) to develop standardised, digital clinical measures that can be used in the development of therapies for Alzheimer’s disease and related dementias. According to the consortium – which includes drugmakers Biogen, Eisai, Eli Lilly and Merck & Co – there is a lack of measures that can be used to determine whether new therapies for Alzheimer’s are actually working.

111

111

Outsourcing Pharma

MARCH 17, 2022

The medication adherence specialist is joining IT4Anxiety, a project focused on dealing with anxiety in patients with mental disorders, via technology.

59

59

Pharmacy Friday Pearls

MARCH 16, 2022

Download PDF. Introduction . 1. Commonly identified as symptoms, including nausea, cyclic vomiting and abdominal pain, that are refractory to available antiemetics and analgesics. 2. Patients tend to take compulsive hot baths/showers for symptom relief. 3. Characteristically distinguished from cyclic vomiting syndrome, these symptoms are usually preceded by years of chronic cannabis use and symptoms are typically resolved with cessation of cannabis use. 4.

40

40

Med Ed 101

MARCH 16, 2022

I’ve been doing quite a bit of long term care consulting lately and I’ve been trying to pay attention to which medications and medication classes I have been targeting in an effort to reduce polypharmacy. Here are my top 5 targets to reduce medications in long term care. Also be sure to check out my […]. The post Top 5 Targets To Reduce Medications In Long Term Care appeared first on Med Ed 101.

40

40

pharmaphorum

MARCH 15, 2022

The new normal is already here. Get used to it. The COVID-19 pandemic has radically disrupted traditional medical society conferences in a way that could scarcely have been imagined in 2019. The vast majority of societies were able to transition their planned physical events to virtual formats within remarkably short periods of time, and some delivered impressive attendee experiences.

Labelling 105

Labelling Vaccines Communication 105

Outsourcing Pharma

MARCH 16, 2022

A leader from the trial platform company discusses how patient experience can be enhanced when the clinical trial team shares a background with the subjects.

52

52

Pharma Times

MARCH 18, 2022

With the significant increase in entries this year, the competition to name the finalists proved incredibly tough. The International Clinical Researcher judging panel, however, have made their decisions and the finalists have now been announced.

44

44

pharmaphorum

MARCH 14, 2022

Novartis may be planning to sell off its generics business Sandoz, but that hasn’t stopped it investing in the unit ahead of a decision on its future later this year. This morning, Sandoz announced it has acquired medical and drug delivery device specialist Coalesce Product Development, bolstering its capabilities for the development of respiratory medicines and ‘complex’ generics.

Generic Medicine 104

Generic Medicine 104

pharmaphorum

MARCH 18, 2022

Gaming industry veteran Jon David, responsible for highly-downloaded mobile games, including the Bejeweled and Plants vs Zombies franchises, has moved into the digital health arena by taking a senior position at Akili Interactive Labs. As Akili’s chief product officer, his role will be to make sure that the company’s game-based therapies are as engaging as “high-end entertainment,” ensuring that they are fun to play, as well as therapeutically effective.

FDA 98

FDA 98

pharmaphorum

MARCH 15, 2022

Life science companies invest a significant number of resources to engage physicians and patient advocates. However, companies often fall short when it comes to engaging patients in a meaningful way during the product development process. In a new whitepaper, Best Practice Guide: Insights Management and Virtual Patient Engagement, Within3 provides a detailed roadmap to help life science companies navigate engagement in the virtual world.

98

98

pharmaphorum

MARCH 14, 2022

Janssen’s Roz Bekker, VP Commercial Strategy for Infectious Diseases & Vaccines at Janssen EMEA, looks at how COVID-19 has reinforced the value of connecting with people, and how healthcare systems need ongoing reform to deliver more holistic, human-centric care. The connecting effect of COVID-19. No matter where you are in the world, COVID-19 has had an impact.

Vaccines 98

Vaccines Pharmaceutical Companies Pharmaceutical Companies Hospitals 98

pharmaphorum

MARCH 15, 2022

Sanofi has agreed a deal with life sciences investor Blackstone to help fund clinical trials of a new formulation of Sarclisa for blood cancer multiple myeloma, accelerating its development. Blackstone will provide €300 million in funding for the project, which will focus on a subcutaneous formulation of Sarclisa (carfilzomib) that is due to start a pivotal study later this year.

97

97

pharmaphorum

MARCH 15, 2022

The latest version of Abbott’s FreeStyle Libre continuous glucose monitor is now available via the NHS to eligible people with diabetes in the UK. Abbott’s wearable FreeStyle Libre 3 device – which is billed as the smallest and thinnest real-time CGM system available – sends glucose readings every minute directly to the user’s smartphone for up to 14 days, allowing them to adjust treatment as needed.

97

97

pharmaphorum

MARCH 18, 2022

AstraZeneca (AZ), GlaxoSmithKline (GSK), Sanofi, Allergan and Britannia Pharma have been reprimanded for running advertisements that breached the Association of British Pharmaceutical Industry (APBI) code of practice. Complaints upheld by the Prescription Medicines Code of Practice Authority (PMCPA) include two against AZ and Allergan – now part of AbbVie – related to promotion of medicines on social media sites, including LinkedIn.

Vaccines 64

Vaccines 64

pharmaphorum

MARCH 14, 2022

Shares in Sanofi were on the slide this morning after the drugmaker revealed that one of its top pipeline prospects – selective oestrogen receptor degrader (SERD) amcenestrant – stumbled in a mid-stage breast cancer trial. The phase 2 AMEERA-3 trial was testing amcenestrant in women aged 18 and over with hormone receptor-positive, HER2-negative advanced breast cancer, and showed no benefit in progression-free survival for the drug compared to physician’s choice endocrine therapy.

64

64